People · Operator
Named in public records as an officer, director or promoter · active 2025–2025 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Dualitas Therapeutics, Inc. | — | Biotechnology | Series B | $32.6M | $150.4M | 2025 |
Forbes Huang at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Forbes Huang on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Ross | 1 | 18 |
| Mark McDade | 1 | 5 |
| Richard Murray | 1 | 5 |
| Thomas Hudson | 1 | 4 |
| Nikola Trbovic | 1 | 3 |
| Neil Weir | 1 | 2 |
| Greg Lazar | 1 | 1 |
| Alicia Levey | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.